Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
71,118,095
-
Share change
-
-17,439,117
-
Total reported value
-
$970,947,825
-
Put/Call ratio
-
20%
-
Price per share
-
$13.63
-
Number of holders
-
262
-
Value change
-
-$282,516,518
-
Number of buys
-
97
-
Number of sells
-
142
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2021
As of 31 Dec 2021,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
262 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,118,095 shares.
The largest 10 holders included
ARK Investment Management LLC, CITIGROUP INC, BSN Capital Partners Ltd, Mondrian Investment Partners LTD, MACQUARIE GROUP LTD, GOLDMAN SACHS GROUP INC, Parametric Portfolio Associates LLC, NORTHERN TRUST CORP, BlackRock Inc., and FMR LLC.
This page lists
267
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.